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j ourna l homepage: http : / /www. journa ls .e lsev ie r .com/ i jc -metabo l ic -and-endocr ineErectile dysfunction and cardiovascular diseaseErectile dysfunction (ED) is a common sexual disorder that affects
N500 000 men per year. With the increasing incidences of ED, quality
of life has been impacted both among ED patients and their partners.
ED is associated with emotional distress that can signiﬁcantly affect
important psychosocial factors, such as conﬁdence and self-esteem,
and may damage personal relationships [1]. However, the patho-
physiologic mechanism involved in the causation of ED is multifactorial
and not well delineated. Several recent studies have conﬁrmed that ED
is the result of multiple interrelated comorbid conditions such as
cardiovascular disease, and ED has been recognized as a potential
independent risk factor and/or predictor for cardiovascular disease.
Recently, several studies have found that ED and cardiovascular disease
share a lot of common risk factors such as age, hypercholesterolemia,
insulin resistance and diabetes, hypertension, smoking, metabolic
syndrome, and obesity [2], and share a common pathophysiological
basis of etiology and progression, e.g. impairment of endothelial
function, atherosclerosis [3], and subclinical inﬂammation [4]. It has
also been reported that under a given atherosclerotic burden condition,
the smaller penile arteries suffer obstruction earlier than the larger
coronary arteries. Also, at the same degree of endothelial dysfunction
penile arteries will be symptomatic, while subclinical in the larger
coronary arteries because penile arteries have a greater endothelial
surface and erection itself requires a large degree of vasodilation to
occur when compared with coronary arteries [5]. ED may precede
cardiovascular disease by a signiﬁcant period that usually ranges from
2 to 5 years (3 years in average) [6].
The underlying mechanism by which the pathogenesis of ED
was regulated includes the nitric oxide (NO)/cyclic guanosine
monophosphate (cGMP)/protein kinase G (PKG) pathway, the RhoA/
Rho-associated protein kinase (ROCK) signaling pathway, reactive
oxygen species (ROS), the renin–angiotensin system (RAS) and tumor
necrosis factor-alpha (TNF-α) [7].
The most common concern of men with ED and their partners is
that when can sexual activity be safely resumed after a cardiovascu-
lar event. However, a very low percent of cardiac patients receive
formal sexual counseling. Many couples have anxiety and fear re-
garding sexual needs [8]. One follow-up study, which had recruited
men aged 55 years or older, has found that after following an initial
report of ED, 2% of men had experienced an initial CV event at
1 year, and 11% had experienced a CV event by 5 years [9]. It has
also been reported that ED is associated with increased risk of
cardiovascular events and all-cause mortality. Thus, ED may be
used to predict the risk of future fatal and non-fatal cardiovascular
events (e.g. myocardial infarction and revascularization) and total
mortality in the general population and in high cardiovascular risk
patients [10]. So, it is important for physicians, especially forhttp://dx.doi.org/10.1016/j.ijcme.2015.08.001
2214-7624/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access articlcardiologist, to understand that the relationship between ED and
cardiovascular disease is not a coincidence but rather a warning sig-
nal. Furthermore, the symptoms of ED normally arise before the
symptoms of a cardiovascular event [11]. That is to say ED may
serve as an early warning for cardiovascular disease.
Although ED may be the only reason for men to see a doctor,
this presents a good chance for doctors not only to treat erectile dys-
function, but to perform opportunistic screening for cardiovascular
risks as well. It is very important for these patients with sexual
dysfunction to have their cardiac risk evaluated and to initiate sec-
ondary prophylaxis with regard to any risks aggressively as early as
possible.
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